Why was a National Allergy Strategy developed?
Allergic disease has become an increasingly important chronic disease and public health issue in Australia and other developed countries over the last two decades, contributing to increased demand for medical services, significant economic cost of care and reduced quality of life of people with allergic disease and their carers. Currently affecting more than 4 million Australians, the rapid and continuing rise of allergic disease is therefore a serious public health issue that requires action by all levels of government and the community.
To address these issues, in 2014-2015, the Australasian Society of Clinical Immunology and Allergy (ASCIA) and Allergy & Anaphylaxis Australia (A&AA), as the leading medical and patient organisations for allergy in Australia, developed and launched the first National Allergy Strategy for Australia, in collaboration with other stakeholder organisations. An important guiding principle is that the National Allergy Strategy remains patient and consumer focused. This is reflected in the Mission of the National Allergy Strategy:
To improve the health and quality of life of Australians with allergic diseases, and minimise the burden of allergic diseases on individuals, their carers, healthcare services and the community.
For more information about the National Allergy Strategy, visit the National Allergy Council website